التداخل بين إيتراكونازول وريلبيفيرين

Coadministration of EDURANT or EDURANT PED and drugs that inhibit CYP3A may result in increased plasma concentrations of rilpivirine.

Azole Antifungal Agents: fluconazole itraconazole ketoconazole This interaction study has been performed with a dose higher than the recommended dose for EDURANT assessing the maximal effect on the coadministered drug.

The dosing recommendation is applicable to the recommended doses of EDURANT once daily. posaconazole voriconazole ↑ rilpivirine ↓ ketoconazole Concomitant use of EDURANT or EDURANT PED with azole antifungal agents may cause an increase in the plasma concentrations of rilpivirine (inhibition of CYP3A enzymes).

No rilpivirine dose adjustment is required when EDURANT or EDURANT PED is coadministered with azole antifungal agents.

Clinically monitor for breakthrough fungal infections when azole antifungals are coadministered with EDURANT or EDURANT PED.